NCT04522687
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +15 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
NSCLC
Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.
357 public trials
121 recruiting studies
NSCLC trial results
Enrolling by Invitation
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
NCT06885424
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +67 more
- Locations
-
- Banner Health Gilbert, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
- NYU Langone Medical Center New York, United States
Enrolling by Invitation
Perioperative Treatment Outcomes of Early NSCLC
NCT06610240
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Zhong Hua Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Multimodal Ablation Combined With Perioperative Tislelizumab and Chemotherapy for Resectable II-IIIB NSCLC
NCT07729670
- Conditions
- NSCLC
- Locations
-
Not specified
NCT07689812
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Advanced Solid Tumors Cancer, +54 more
- Locations
-
Not specified
Not Yet Recruiting
Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC
NCT07671092
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
- Locations
-
- Research Facility Christchurch, New Zealand
Not Yet Recruiting
SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer
NCT07697586
- Conditions
- NSCLC
- Locations
-
- Jilin Cancer Hospital Jilin City, China
- Shanghai East Hospital, Tongji University Shanghai, China
Not Yet Recruiting
A Phase Ib Study of Tislelizumab Plus SYS6010 in Immunotherapy-Pretreated Locally Advanced or Metastatic NSCLC
NCT07692048
- Conditions
- NSCLC
- Locations
-
- West China Hospital, Sichuan University Chengdu, Please Select, China
Not Yet Recruiting
An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer
NCT07685041
- Conditions
- NSCLC
- Locations
-
Not specified
Not Yet Recruiting
Comparative ¹⁸F-FDG and ⁶⁸Ga-MY6349 PET/CT Imaging for Assessing TROP2 ADC Therapeutic Efficacy in EGFR-TKI Resistant Advanced NSCLC
NCT07685197
- Conditions
- EGFR Activating Mutation, EGFR-TKI-resistant Non-Small Cell Lung Cancer, NSCLC, +2 more
- Locations
-
Not specified